leadf
logo-loader
viewAkorn, Inc.

Generic drugs firm Akorn confirms takeover talks with Germany's Fresenius

In separate statements, both companies said there was no certainty the discussions would lead to a deal

Drugs
Illinois-based Akorn – which had sales of US$1.1bn last year - has a current market cap of about US$3.7bn

US generic drugs manufacturer Akorn Inc (NASDAQ:AKRX) has confirmed it is in takeover talks with German healthcare firm Fresenius SE.

In separate statements, both companies said there was no certainty the discussions would lead to a deal.

Illinois-based Akorn – which had sales of US$1.1bn last year  - has a current market cap of about US$3.7bn.

Asthma to heart medicines …

The Nasdaq-listed group makes branded and generic versions of ophthalmic, injectable and non-injectable drugs with manufacturing facilities in the US and outside the country.

Its biggest brand-name drugs include asthma treatment, Xopenex and heart medicine, Akten.

In premarket trading, Akorn shares were over 12% higher at US$33.45 each, having soared 18% higher on Friday having following reports of a bid.

Quick facts: Akorn, Inc.

Price: - -

NASDAQ:AKRX
Market: NASDAQ
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Condor Gold adds second drill rig as they look to ramp up drill program at...

Condor Gold (AIM: CNR- TSE: COG) CEO Mark Child joined Steve Darling from Proactive with news the company has added a second drill rig on their La India Project, in Nicaragua. Child telling Proactive, this rig will help speed up infill drilling on their current 4000-metre program. The...

9 hours, 55 minutes ago

2 min read